Login to Your Account

Nonprofits Become Funding Source for Smaller Biotechs

By Catherine Hollingsworth

Monday, May 19, 2008
In their search for cures, many nonprofit disease foundations are playing the role of investor, funneling research dollars to biotechnology companies. But unlike a venture capital firm, these donor-based patient advocacy groups don't expect a financial return on their "investment" in return for research grants. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription